Test kit used in the assessment of breast cancer patients for whom Herceptin therapy is being considered. BioGenex brand InSite HER-2/neu IHC Kit, Manual; Model Numbers: RD134-60K; Lot Numbers: RD1340205, RD1340205X, RD1340205Y
FDA Recall Z-0606-06 · Posted 2006-03-15
Recalling FirmBiogenex Laboratories
Recall StatusTerminated
Product CodeMVC
Date Initiated2006-02-09
Date Terminated2006-08-23
Product Quantity14 units
Reason for Recall
Products produce granular staining in immunostained tissue sections, which may lead to misdiagnosis due to false positive result.
Firm Action
On 2/9/06, the firm issued letters via UPS to all of its consignees, informing them of the affected products and providing instructions on the recall.
Root Cause
Other
Distribution Pattern
Nationwide. Italy, and United Kingdom. The product was released for distribution to 21 consignees nationwide to CA, FL, GA, IA, IL, NC, NJ, NY, TX, VT, WA, and WI. One VA account: VA Medical Center, Gwen Levy, Bld. 500, Room 1238, 11301 Wilshire Blvd., Los Angeles, CA 90073. 2 overseas consignees distributed the product to Italy (Space Imports Export SPL, Via Ranzato, 12, 1-20128 Milano, Italy and United Kingdom (Launch Diagnosis, West Yoke Farm unit 11, Michaels, Lane, Sevenoaks, Kent, TN15 7EP United Kingdom
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.